CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

CANTAB tests predict functional decline in patients with amnestic mild cognitive impairment

We presented a novel, predictive model of functional decline at CTAD 2018. The model suggests that CANTAB PAL and SWM provide essential screening information when recruiting patients with amnestic mild cognitive impairment into Alzheimer’s disease clinical trials.

web-based testing, wearables, voice, virtual clinical trials, technology, swm, stigma, social cognition, smartphones, schizophrenia research, schizophrenia, research funding, research, remote testing, regulations, recruitment, rare disease, prodromal, pro-cognitive, press release, presenteeism, precision psychiatry, pre-clinical, poster, personalised medicine, patient-centric, patient recruitment, patient engagement, parkinson's disease, pal, paired associates learning, ots, occupational health, normative data, neurotech, neuroscience, near-patient testing, multiple sclerosis, ms, modelling, mental wellbeing, mental health, mdd, mci, major depression, machine learning, ied, high-frequency testing, high frequency, healthcare, guide, grant, funding, fatigue, ert, epidemiology, emotion recognition, ebt, ebbinghaus, early career researchers, early alzheimer's disease, drug development, digital tools, digital health, depression, dementia, cognitive testing, cognitive science, cognitive safety, cognitive research, cognitive load, cognitive impairment, cognitive function, cognitive dysfunction, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, chronic illness, chronic health conditions, cgt, cantab testimonial, cantab research grant, cantab for clinical trials, cantab, brain health, biomarkers, awards, automatic speech recognition, autism, attention, asd, alzheimer's disease, affective cognition, adolescents, absenteeism,